Sunday, December 31, 2006
Entrez PubMed
Entrez PubMed: "Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary."
Friday, December 29, 2006
Friday, December 22, 2006
Saturday, December 02, 2006
Friday, December 01, 2006
CancerWise - December 2006 - Trial Studies Ovarian Cancer Screening Test
CancerWise - December 2006 - Trial Studies Ovarian Cancer Screening Test
Trial Studies Ovarian Cancer Screening Test
Healthy Postmenopausal Women Being Recruited
Should women be screened for ovarian cancer? Researchers hope to answer that question through a new study in which blood and urine samples from healthy, postmenopausal women are collected and analyzed.
Goal of study
M. D. Anderson researchers conducting the Low-Risk Ovarian Cancer Study hope the clinical trial and others like it one day may lead to a more effective screening test to increase early detection of the disease.
“Unfortunately, there’s no effective screening test, like the mammogram or colonoscopy, to detect ovarian cancer at an early stage when the chance of cure is greatest,” says Karen Lu, M.D., associate professor in M. D. Anderson’s Department of Gynecologic Oncology. “As a result, more than two-thirds of all ovarian cancers are found at an advanced stage.”
The purpose of the study is to not only evaluate a blood marker called CA-125 over a period of time, but also to create new markers for ovarian cancer detection. Urine also will be collected so that its proteins can be used to help create new markers.
ScienceDirect - Gynecologic Oncology : Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial pr
ScienceDirect - Gynecologic Oncology : Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: A prospective cohort study: "Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: A prospective cohort study"
Thursday, November 30, 2006
Thursday, November 23, 2006
How much will Herceptin really cost? -- Barrett et al. 333 (7578): 1118 -- BMJ
How much will Herceptin really cost? -- Barrett et al. 333 (7578): 1118 -- BMJ: "So we could fund Herceptin if we did not treat 355 patients receiving adjuvant treatment (16 of whom would be cured) or 208 patients receiving palliative chemotherapy, and if we found �0.5m from another source. These untreated patients will be people we know. We will be the ones to tell them they are not getting a treatment that has been proved to be effective, which costs relatively little, because it is not the 'treatment of the moment.'"
Entrez PubMed
Entrez PubMed: "Clinical characteristics of patients with sporadic colorectal cancer and primary cancers of other organs"
Tuesday, November 21, 2006
Monday, November 20, 2006
2006 November - Cancer - Our National Shame - The killing cost of drug treatment
globeandmail.com: The killing cost of drug treatment
http://tinyurl.com/ykrl7s
Cancer: Our national shame
The killing cost of drug treatment
For a health-care system based on the principle of equal access, the reality is tragically different
Sunday, November 19, 2006
BMJ: Breast Cancer News - Internet-Based Information Highly Accurate in Internet Breast Cancer Support Groups
* The information in the postings was highly accurate.
* Only 0.22% of postings had false or misleading information.
* 70% of the false or misleading postings were corrected by other participants in the support groups within a median time of four hours and 33 minutes.
Subscribe to:
Posts
(
Atom
)
